株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

除細動器の世界市場 ~2025年:植込み式 (経静脈ICD・単腔&二腔ICD・CRT-D・S-ICD)・体外式 (手動・AED・ウェアラブル)

Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD), External (Manual, AED, Wearable)), End User (Hospitals, Pre-hospital, Public Access, Home care) - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 925794
出版日 ページ情報 英文 159 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.77円で換算しております。
除細動器の世界市場 ~2025年:植込み式 (経静脈ICD・単腔&二腔ICD・CRT-D・S-ICD)・体外式 (手動・AED・ウェアラブル) Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD), External (Manual, AED, Wearable)), End User (Hospitals, Pre-hospital, Public Access, Home care) - Global Forecast to 2025
出版日: 2020年02月11日 ページ情報: 英文 159 Pages
概要

世界の除細動器の市場は予測期間中3.4%のCAGR (年間複合成長率) で推移し、2019年の96億米ドルから、2025年には117億米ドルの規模に成長すると予測されています。標的疾患の有病率の上昇、PAD (市民がアクセス可能な除細動器) 提供への注目の高まり、除細動器のトレーニングおよび意識向上プログラムへの焦点拡大などの要因が同市場の成長を推進しています。しかし一方で、植込み式および自動体外式除細動器の使用に関する課題、頻繁な製品リコールなどが市場のさらなる成長の障壁となっています。製品タイプ別で見ると、使用の容易な製品の開発に対する関心の高まり、公共の場所へのAED設置に向けた政府支援の増加などの要因から、体外式除細動器の部門が予測期間中最大のCAGRで成長すると予測されています。またエンドユーザー別では、病院・診療所・心臓センターの部門が最大の市場シェアを記録し、予測期間中もこの位置付けを維持する見通しです。心臓移植手術の増加や先進諸国での償還利用などの要因が同部門の成長を推進しています。

当レポートでは、世界の除細動器の市場を調査し、市場および製品の概要、市場成長への各種影響因子および市場機会の分析、関連法規制、製品タイプ・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

925794_4.1 DEFIBRILLATORS MARKET OVERVIEW_FIGURE 11

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • マクロ経済指標
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 産業動向
  • 法規制シナリオ

第6章 除細動器市場の分析・予測:タイプ別

  • イントロダクション
  • 植込み式除細動器
    • 経静脈
      • 両心室ICD/CRT-D
      • 二腔ICD
      • 単腔ICD
    • 皮下
  • 体外式除細動器
    • 手動・半自動
    • 完全自動
    • ウェアラブル

第7章 除細動器市場の分析・予測:エンドユーザー別

  • イントロダクション
  • 病院・診療所・心臓センター
  • プレホスピタルケア環境
  • パブリックアクセス市場
  • 代替介護施設
  • 在宅ケア環境

第8章 除細動器市場の分析・予測:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合環境

  • イントロダクション
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • ベンダーダイブ分析
  • 競合シナリオ

第10章 企業プロファイル

  • BIOTRONIK
  • BOSTON SCIENTIFIC
  • CU MEDICAL SYSTEMS
  • KONINKLIJKE PHILIPS N.V.
  • MEDIANA
  • MEDTRONIC
  • METSIS MEDIKAL
  • MICROPORT
  • MINDRAY MEDICAL
  • 日本光電工業
  • PHYSIO-CONTROL (PART OF STRYKER CORPORATION)
  • PROGETTI MEDICAL EQUIPMENT SOLUTIONS
  • SCHILLER AG
  • ST. JUDE MEDICAL (ABBOTT LABORATORIES)
  • ZOLL MEDICAL CORPORATION (旭化成)

第11章 付録

図表

LIST OF TABLES

  • TABLE 1: RECENT PRODUCT RECALLS BY THE US FDA, 2017-2019
  • TABLE 2: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 3: DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 4: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 5: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 6: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (UNITS)
  • TABLE 7: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 8: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 9: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 10: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 11: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 12: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 13: DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 14: DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 15: SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 16: SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 17: SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 18: SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 19: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 20: EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 21: EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (UNITS)
  • TABLE 22: EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 23: MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 24: MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 25: FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 26: FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 27: WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 28: WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 29: DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 30: DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 31: DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 32: DEFIBRILLATORS MARKET FOR PUBLIC ACCESS MARKETS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 33: DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 34: DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 35: DEFIBRILLATORS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 36: NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 37: NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 38: NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 39: NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 40: NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 41: NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 42: US: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 43: US: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 44: US: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 45: US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 46: CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 47: CANADA: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 48: CANADA: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 49: CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 50: EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 51: EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 52: EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 53: EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 54: EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 55: EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 56: GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 57: GERMANY: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 58: GERMANY: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 59: GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 60: UK: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 61: UK: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 62: UK: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 63: UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 64: FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 65: FRANCE: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 66: FRANCE: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 67: FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 68: ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 69: ITALY: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 70: ITALY: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 71: ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 72: SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 73: SPAIN: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 74: SPAIN: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 75: SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 76: ROE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 77: ROE: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 78: ROE: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 79: ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 80: ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 81: ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 82: ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 83: ASIA PACIFIC: T-ICDS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 84: ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 85: ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 86: JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 87: JAPAN: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 88: JAPAN: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 89: JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 90: CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 91: CHINA: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 92: CHINA: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 93: CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 94: INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 95: INDIA: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 96: INDIA: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 97: INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 98: AUSTRALIA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 99: AUSTRALIA: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 100: AUSTRALIA: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 101: AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 102: SOUTH KOREA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 103: SOUTH KOREA: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 104: SOUTH KOREA: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 105: SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 106: REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 107: REST OF ASIA PACIFIC: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 108: REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 109: REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 110: LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 111: LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 112: LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 113: LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 114: LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 115: LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 116: BRAZIL: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 117: BRAZIL: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 118: BRAZIL: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 119: BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 120: MEXICO: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 121: MEXICO: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 122: MEXICO: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 123: MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 124: REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 125: REST OF LATIN AMERICA: IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 126: REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 127: REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 128: MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 129: MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 130: MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 131: MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 132: MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2017-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: DEFIBRILLATORS MARKET: PRODUCT-BASED ESTIMATION
  • FIGURE 6: DEFIBRILLATORS MARKET: END-USER-BASED ESTIMATION
  • FIGURE 7: DATA TRIANGULATION
  • FIGURE 8: DEFIBRILLATORS MARKET, BY TYPE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 9: DEFIBRILLATORS MARKET SHARE, BY END USER, 2019 VS. 2025
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET
  • FIGURE 11: RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 12: FULLY AUTOMATED EXTERNAL DEFIBRILLATORS SEGMENT TO REGISTER THE HIGHEST GROWTH FROM 2019 TO 2025
  • FIGURE 13: HOSPITALS, CLINICS, AND CARDIAC CENTERS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2025
  • FIGURE 14: ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS
  • FIGURE 15: DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 16: GERIATRIC POPULATION, BY REGION, 2015-2050 (MILLION)
  • FIGURE 17: NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT
  • FIGURE 18: ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT
  • FIGURE 19: KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATORS MARKET, 2016-2019
  • FIGURE 20: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 21: EXTERNAL DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 22: DEFIBRILLATORS MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 23: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 24: KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 25: MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 26: MICROPORT: COMPANY SNAPSHOT
  • FIGURE 27: NIHON KOHDEN: COMPANY SNAPSHOT
  • FIGURE 28: STRYKER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 29: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 30: ASAHI KASEI: COMPANY SNAPSHOT
目次
Product Code: MD 3124

"The global defibrillators market is projected to grow at a CAGR of 3.4%"

The global defibrillators market is expected to reach USD 11.7 billion by 2025 from USD 9.6 billion in 2019, at a CAGR of 3.4%. Factors such as the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. However, issues related to the use of implantable and automated external defibrillators and frequent product calls are expected to restrain the growth of the defibrillators market in the forecast period. The defibrillators market has witnessed significant developments in terms of technological advancements and new product developments.

"The external defibrillators segment is expected to grow at the highest CAGR from 2019 to 2025"

On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is further segmented into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into external defibrillators, and wearable cardioverter defibrillators (WCDs). The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.

"The hospitals, clinics, and cardiac centers segment to dominate the global defibrillators market during the forecast period"

On the basis of end users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2019. A growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.

"APAC is projected to witness the highest growth during the forecast period"

The Asia Pacific defibrillators market is expected to grow at the highest CAGR from 2019 to 2025. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1-25%, Tier 2-30% and Tier 3-45%
  • By Designation - C-level-26%, Director-level-30%, Others-44%
  • By Region - North America-34%, Europe-26%, APAC-23%, RoW-17%

The key players in the defibrillators market include: Medtronic (Ireland), Abbott Laboratories (US), Boston Scientific (Germany), ZOLL Medical Corporation (US), Koninklijke Philips N.V. (Netherlands), BIOTRONIK (Germany), Nihon Kohden (Japan), MicroPort (China), Mediana (South Korea), CU Medical Systems (South Korea), Mindray Medical (China), Physio-Control (US), SCHILLER AG (Switzerland), Progetti Medical Equipment Solutions (Italy), and METsis Medikal (Turkey)

Research Coverage:

This report studies the defibrillators market based on type, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the overall market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on business strategies adopted by the major players in the defibrillators market. The report analyzes the defibrillators market based on type, end user, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the defibrillators market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various defibrillators across geographies.
  • Market Diversification: Exhaustive information about new defibrillator types, untapped geographies, recent developments, and investments in the defibrillators market.
  • Competitive Assessment: In-depth assessment of market ranking, strategies, and products of leading players in the defibrillators market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKETS COVERED
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 END-USER-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 RESEARCH LIMITATIONS & ASSUMPTIONS
    • 2.4.1 LIMITATIONS
    • 2.4.2 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DEFIBRILLATORS MARKET OVERVIEW
  • 4.2 DEFIBRILLATORS MARKET, BY TYPE, 2019 VS. 2025 (USD MILLION)
  • 4.3 DEFIBRILLATORS MARKET, BY END USER, 2019 VS. 2025 (USD MILLION)
  • 4.4 DEFIBRILLATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of target diseases
      • 5.2.1.2 Growing focus on providing public-access defibrillators
      • 5.2.1.3 Training & awareness programs on defibrillators
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Issues related to the use of implantable and automated external defibrillators
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Frequent product recalls
      • 5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS
    • 5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS
    • 5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS
  • 5.4 REGULATORY SCENARIO
    • 5.4.1 EXTERNAL DEFIBRILLATORS
    • 5.4.2 IMPLANTABLE DEFIBRILLATORS

6 DEFIBRILLATORS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators
        • 6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth
      • 6.2.1.2 Dual-chamber ICDs
        • 6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks
      • 6.2.1.3 Single-chamber ICDs
        • 6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks
    • 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market
  • 6.3 EXTERNAL DEFIBRILLATORS
    • 6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
      • 6.3.1.1 Development of technologically advanced AEDs is negatively affecting the market for manual external defibrillators
    • 6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
      • 6.3.2.1 Increasing installation of these devices in public places to drive market growth
    • 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
      • 6.3.3.1 Concerns associated with the use of WCDs are expected to hamper its adoption

7 DEFIBRILLATORS MARKET, BY END USER

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS, CLINICS, & CARDIAC CENTERS
    • 7.2.1 HOSPITALS, CLINICS, & CARDIAC CENTERS-LARGEST END USERS OF DEFIBRILLATORS
  • 7.3 PREHOSPITAL CARE SETTINGS
    • 7.3.1 RISING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH
  • 7.4 PUBLIC ACCESS MARKETS
    • 7.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARREST IS DRIVING THE ADOPTION OF DEFIBRILLATORS
  • 7.5 ALTERNATE CARE FACILITIES
    • 7.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH
  • 7.6 HOME CARE SETTINGS
    • 7.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS-KEY FACTOR DRIVING MARKET GROWTH

8 DEFIBRILLATORS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 US
      • 8.2.1.1 High adoption rate of AEDs in the country to drive market growth
    • 8.2.2 CANADA
      • 8.2.2.1 High burden of CVD in the country is contributing to the growth of the defibrillators market in Canada
  • 8.3 EUROPE
    • 8.3.1 GERMANY
      • 8.3.1.1 Germany dominates the European defibrillators market
    • 8.3.2 UK
      • 8.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth
    • 8.3.3 FRANCE
      • 8.3.3.1 Increasing prevalence of chronic diseases in the geriatric population-a key driver for market growth in France
    • 8.3.4 ITALY
      • 8.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market
    • 8.3.5 SPAIN
      • 8.3.5.1 Increasing number of conferences and awareness programs is supporting the growth of the defibrillators market in Spain
    • 8.3.6 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 JAPAN
      • 8.4.1.1 Presence of a universal insurance scheme in Japan is expected to support market growth
    • 8.4.2 CHINA
      • 8.4.2.1 China is the fastest-growing market for defibrillators in the APAC
    • 8.4.3 INDIA
      • 8.4.3.1 High incidence and prevalence of CVD in the country to drive market growth
    • 8.4.4 AUSTRALIA
      • 8.4.4.1 Government and private bodies are taking measures to make AEDs available at public sites in the country
    • 8.4.5 SOUTH KOREA
      • 8.4.5.1 Rising incidence of cardiac disorders is driving the growth of the defibrillators market in South Korea
    • 8.4.6 REST OF ASIA PACIFIC (ROAPAC)
  • 8.5 LATIN AMERICA
    • 8.5.1 BRAZIL
      • 8.5.1.1 Large obese population has resulted in the increased demand for defibrillators in the country
    • 8.5.2 MEXICO
      • 8.5.2.1 High prevalence of target diseases in the country is the major factor driving the growth of the defibrillators market in Mexico
    • 8.5.3 REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST & AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS, 2018
    • 9.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
    • 9.2.2 EXTERNAL DEFIBRILLATORS MARKET
  • 9.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
  • 9.4 VENDOR INCLUSION CRITERIA
  • 9.5 VENDOR DIVE
    • 9.5.1 VISIONARY LEADERS
    • 9.5.2 INNOVATORS
    • 9.5.3 DYNAMIC DIFFERENTIATORS
    • 9.5.4 EMERGING COMPANIES
  • 9.6 COMPETITIVE SCENARIO
    • 9.6.1 KEY PRODUCT LAUNCHES & APPROVALS (2016-2019)
    • 9.6.2 KEY AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS (2016-2019)
    • 9.6.3 KEY EXPANSIONS (2016-2019)
    • 9.6.4 KEY ACQUISITIONS (2016-2019)

10 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view)*

  • 10.1 BIOTRONIK
  • 10.2 BOSTON SCIENTIFIC
  • 10.3 CU MEDICAL SYSTEMS
  • 10.4 KONINKLIJKE PHILIPS N.V.
  • 10.5 MEDIANA
  • 10.6 MEDTRONIC
  • 10.7 METSIS MEDIKAL
  • 10.8 MICROPORT
  • 10.9 MINDRAY MEDICAL
  • 10.10 NIHON KOHDEN
  • 10.11 PHYSIO-CONTROL (PART OF STRYKER CORPORATION)
  • 10.12 PROGETTI MEDICAL EQUIPMENT SOLUTIONS
  • 10.13 SCHILLER AG
  • 10.14 ST. JUDE MEDICAL (ACQUIRED BY ABBOTT LABORATORIES)
  • 10.15 ZOLL MEDICAL CORPORATION (A PART OF ASAHI KASEI CORPORATION)

Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS